Skip to content

Perioperative Tranexamic Acid (TXA) Administration in Metabolic Bariatric Surgery to Reduce Perioperative bleeding: A Double-blinded, 3-arm Randomized Controlled Trial

Perioperative Tranexamic Acid (TXA) Administration in Metabolic Bariatric Surgery to Reduce Perioperative bleeding: A Double-blinded, 3-arm Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250803003
Enrollment
126
Registered
2025-08-03
Start date
2024-06-25
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To evaluate the effect of Tranexamic Acid (TXA) administration in perioperative bleeding, postoperative respiratory-related pain, and prolonged hospital stay in patients undergoing laparoscopic sleeve gastrectomy (LSG) Laparoscopic sleeve gastrectomy, bariatric surgery, obesity, bleeding, tranexamic acid, bariatric

Interventions

Non TXA - placebo (Normal saline 0.9%) ,Patients receiving IV TXA 1g 30 minutes prior to induction , Patients receiving IV TXA 1g 30 minutes prior to induction + 3 regular dose 8 hours apart of IV TXA
Group 1 - Controlled group,Group 2 - TXA,Group 3 - TXA3

Sponsors

University Kebangsaan Malaysia (UKM)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing laparoscopic sleeve gastrectomy (LSG) 2. American Society of Anesthesiology (ASA) Classification I and II 3. 18 to 65 years old

Exclusion criteria

Exclusion criteria: 1. Patients with underlying hematological/coagulation disorder 2. Patients on antiplatelet 3. Patients with contradiction/allergic to contents in TXA 4. Previous history of VTE 5. Previous abdominal surgery except lower segment cesarean section (LSCS)/ gynaecological procedure 6. Patients with underlying IHD, CKD stage IIIB and above

Design outcomes

Primary

MeasureTime frame
Intra operative bleeding intraoperative Gauze weight,The amount of hemostatic sutures used to secure bleeding intraoperative Number of sutures,Pre and postoperative hemoglobin counts Pre and post operative Hemoglobin level

Secondary

MeasureTime frame
Length of hospital stay After discharge Days of hospital stay post operatively,Adverse effect and complications Pre/Intra and post operative Documented using proforma,Pain score Postoperative Visual Analogue Score (VAS),Spirometry efforts Postoperative Spirometry reading

Countries

Malaysia

Contacts

Public ContactMang Ning Ong

Hospital Canselor Tuanku Muhriz

katherinneong@gmail.com60122828711

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026